18 May – 21 May 2019 in MELBOURNE CONVENTION AND EXHIBITION CENTRE, MELBOURNE, VICTORIA, AUSTRALIA
Safety of certolizumab pegol over 48 weeks in plaque psoriasis phase 3 trials
Identification of clinical and biomarker parameters associated with long-term maintenance of PASI 90 response following guselkumab treatment-withdrawal in psoriasis
Omalizumab for the treatment of acute urticarial drug eruption
Overcoming barriers to lifestyle modification in hidradenitis suppurativa
See and treat skin cancer clinic in dermatology – A single centre pilot study
Mycobacterium abscesses cutaneous infection during ustekinumab treatment in Crohn’s disease – A case report and review of literature
The hair clinic – What have we learned after 28 years?
Immunophenotyping of high risk head and neck SCC with imaging mass cytometry
Chronic unilateral suppurative cribriform ulcers in an elderly female
Immunohistochemical features of anti-PD1 induced lichenoid reactions in patients with metastatic melanoma with varied clinical responses
How to become a dermatologist in the Netherlands!
Air travel induced cutaneous leucocytoclastic vasculitis
Acute non–sexually acquired genital ulceration in a post-partum woman
2023 Dermcoll, 55TH ANNUAL SCIENTIFIC MEETING, THE ART OF DERMATOLOGY
2022 Dermcoll, 54TH ANNUAL SCIENTIFIC MEETING, THE ART OF DERMATOLOGY
